In a Nod to Senator Reverend Warnock's Nationally-Recognized Efforts to Cap Insulin at $35 a Month, Insulin Manufacturer Eli Lilly Announces $35 a Month Cap
March 02, 2023
March 02, 2023
WASHINGTON, March 2 -- Sen. Raphael G. Warnock, D-Georgia, issued the following news release:
U.S. Senator Reverend Raphael Warnock (D-GA) applauded Eli Lilly's announcement to cap insulin costs at $35 a month. The announcement is a nod to Senator Warnock's months-long campaign to cap insulin costs at $35 a month and his successful effort to cap insulin costs at $35 a month for seniors. According to Eli Lilly, the cost cap applies to both insured and uninsured insulin user . . .
U.S. Senator Reverend Raphael Warnock (D-GA) applauded Eli Lilly's announcement to cap insulin costs at $35 a month. The announcement is a nod to Senator Warnock's months-long campaign to cap insulin costs at $35 a month and his successful effort to cap insulin costs at $35 a month for seniors. According to Eli Lilly, the cost cap applies to both insured and uninsured insulin user . . .